A partial form of inherited human USP18 deficiency underlies infection and inflammation.
A partial form of inherited human USP18 deficiency underlies infection and inflammation.
复制标题
DOI:
10.1084/jem.20211273
复制
发表时间:
2022-04-04
期刊:
影响因子:
--
通讯作者:
Bogunovic D
中科院分区:
文献类型:
--
作者:
Martin-Fernandez M;Buta S;Le Voyer T;Li Z;Dynesen LT;Vuillier F;Franklin L;Ailal F;Muglia Amancio A;Malle L;Gruber C;Benhsaien I;Altman J;Taft J;Deswarte C;Roynard M;Nieto-Patlan A;Moriya K;Rosain J;Boddaert N;Bousfiha A;Crow YJ;Jankovic D;Sher A;Casanova JL;Pellegrini S;Bustamante J;Bogunovic D
Martin-Fernandez et al. describe patients with partial USP18 deficiency, which underlies both type I interferonopathy and Mendelian susceptibility to mycobacterial disease (MSMD). This work delineates the lack of negative regulation of the IFN-I signaling pathway leading to depression of the IFN-γ–IL12 loop as a cause of MSMD. Human USP18 is an interferon (IFN)-stimulated gene product and a negative regulator of type I IFN (IFN-I) signaling. It also removes covalently linked ISG15 from proteins, in a process called deISGylation. In turn, ISG15 prevents USP18 from being degraded by the proteasome. Autosomal recessive complete USP18 deficiency is life-threatening in infancy owing to uncontrolled IFN-I–mediated autoinflammation. We report three Moroccan siblings with autoinflammation and mycobacterial disease who are homozygous for a new USP18 variant. We demonstrate that the mutant USP18 (p.I60N) is normally stabilized by ISG15 and efficient for deISGylation but interacts poorly with the receptor-anchoring STAT2 and is impaired in negative regulation of IFN-I signaling. We also show that IFN-γ–dependent induction of IL-12 and IL-23 is reduced owing to IFN-I–mediated impairment of myeloid cells to produce both cytokines. Thus, insufficient negative regulation of IFN-I signaling by USP18-I60N underlies a specific type I interferonopathy, which impairs IL-12 and IL-23 production by myeloid cells, thereby explaining predisposition to mycobacterial disease.
登录
查看更多内容
DOI:
10.1056/nejmoa1312625
发表时间:
2014-08-07
期刊:
The New England journal of medicine
影响因子:
--
作者:
Liu Y;Jesus AA;Marrero B;Yang D;Ramsey SE;Sanchez GAM;Tenbrock K;Wittkowski H;Jones OY;Kuehn HS;Lee CR;DiMattia MA;Cowen EW;Gonzalez B;Palmer I;DiGiovanna JJ;Biancotto A;Kim H;Tsai WL;Trier AM;Huang Y;Stone DL;Hill S;Kim HJ;St Hilaire C;Gurprasad S;Plass N;Chapelle D;Horkayne-Szakaly I;Foell D;Barysenka A;Candotti F;Holland SM;Hughes JD;Mehmet H;Issekutz AC;Raffeld M;McElwee J;Fontana JR;Minniti CP;Moir S;Kastner DL;Gadina M;Steven AC;Wingfield PT;Brooks SR;Rosenzweig SD;Fleisher TA;Deng Z;Boehm M;Paller AS;Goldbach-Mansky R
通讯作者:
Goldbach-Mansky R
影响因子:
39.3
作者:
Liu T;Zhang L;Joo D;Sun SC
通讯作者:
Sun SC
DOI:
10.1084/jem.20151529
发表时间:
2016-06-27
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Meuwissen ME;Schot R;Buta S;Oudesluijs G;Tinschert S;Speer SD;Li Z;van Unen L;Heijsman D;Goldmann T;Lequin MH;Kros JM;Stam W;Hermann M;Willemsen R;Brouwer RW;Van IJcken WF;Martin-Fernandez M;de Coo I;Dudink J;de Vries FA;Bertoli Avella A;Prinz M;Crow YJ;Verheijen FW;Pellegrini S;Bogunovic D;Mancini GM
通讯作者:
Mancini GM
DOI:
10.1126/science.aaa4282
发表时间:
2015-08-07
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Okada S;Markle JG;Deenick EK;Mele F;Averbuch D;Lagos M;Alzahrani M;Al-Muhsen S;Halwani R;Ma CS;Wong N;Soudais C;Henderson LA;Marzouqa H;Shamma J;Gonzalez M;Martinez-Barricarte R;Okada C;Avery DT;Latorre D;Deswarte C;Jabot-Hanin F;Torrado E;Fountain J;Belkadi A;Itan Y;Boisson B;Migaud M;Arlehamn CSL;Sette A;Breton S;McCluskey J;Rossjohn J;de Villartay JP;Moshous D;Hambleton S;Latour S;Arkwright PD;Picard C;Lantz O;Engelhard D;Kobayashi M;Abel L;Cooper AM;Notarangelo LD;Boisson-Dupuis S;Puel A;Sallusto F;Bustamante J;Tangye SG;Casanova JL
通讯作者:
Casanova JL
影响因子:
4.1
作者:
Francois-Newton, Veronique;Livingstone, Mark;Pellegrini, Sandra
通讯作者:
Pellegrini, Sandra